Gilmore O’Neill

2.6k citations

27 papers · 2.0k indexed · h-index 20

Impact in

Pathology and Forensic Medicine top 1%
- Multiple Sclerosis Research Studies
Neurology top 2%
- Amyotrophic Lateral Sclerosis Research
- Peripheral Neuropathies and Disorders

Papers in

Pathology and Forensic Medicine 9
- Multiple Sclerosis Research Studies 9
Rheumatology 7
- Rheumatoid Arthritis Research and Therapies 5

Co-authors: Eva Havrdová Jacob Elkins Ralf Gold Xavier Montalbán Ludwig Kappos Krzysztof Selmaj Katherine Riester John Rose
Journals: Neurology (6 papers)The Lancet Neurology (2 papers)The Lancet (2 papers)PLoS ONE (2 papers)Patient Preference and Adherence (1 paper)
Partner nations: United States Germany United Kingdom

In The Last Decade

Gilmore O’Neill

27 papers receiving 1.9k citations

Peers

Countries citing papers authored by Gilmore O’Neill

Since Specialization

Citations

This map shows the geographic impact of Gilmore O’Neill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilmore O’Neill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilmore O’Neill more than expected).

Fields of papers citing papers by Gilmore O’Neill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilmore O’Neill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilmore O’Neill. The network helps show where Gilmore O’Neill may publish in the future.

Co-authors

The 25 scholars most cited alongside Gilmore O’Neill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gilmore O’Neill Line = papers co-authored together Gilmore O’Neill links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction Patient Preference and Adherence ·Mar Tintoré, Adrienne O'Shea, Kathleen Costello, Martin Duddy, David Jones, Nancy Law, Gilmore O’Neill, Antonio Uccelli, Robert Weissert, Sibyl Wray	2016	61
2	Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis New England Journal of Medicine ·Ludwig Kappos, Heinz Wiendl, Krzysztof Selmaj, Douglas L. Arnold, Eva Havrdová, Alexey Boyко, Michael D. Kaufman, John Rose, Steven J. Greenberg, Marianne T. Sweetser, Katherine Riester, Gilmore O’Neill, Jacob Elkins	2015	199
3	First-In-Human, Double-Blind, Placebo-Controlled, Randomized, Dose-Escalation Study of BG00010, a Glial Cell Line-Derived Neurotrophic Factor Family Member, in Subjects with Unilateral Sciatica PLoS ONE ·Paul Rolan, Gilmore O’Neill, Eve Versage, Jitesh Rana, Yongqiang Tang, Gerald R. Galluppi, Ernesto Aycardi	2015	23
4	Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial The Lancet Neurology ·Gavin Giovannoni, Ralf Gold, Krzysztof Selmaj, Eva Havrdová, Xavier Montalbán, Ernst‐Wilhelm Radue, Dusan Stefoski, Manjit McNeill, Lakshmi Amaravadi, Marianne T. Sweetser, Jacob Elkins, Gilmore O’Neill	2014	73
5	The Safety and Efficacy of Daclizumab HYP in Relapsing-Remitting Multiple Sclerosis in the SELECTION Extension Study: Primary Results (S01.001) Neurology ·Gavin Giovannoni, Ralf Gold, Krzysztof Selmaj, Eva Havrdová, Xavier Montalbán, Ernst‐Wilhelm Radue, Dusan Stefoski, Manjit McNeill, Jitesh Rana, Jacob Elkins, Gilmore O’Neill	2013	3
6	Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial The Lancet ·Ralf Gold, Gavin Giovannoni, Krzysztof Selmaj, Eva Havrdová, Xavier Montalbán, Ernst‐Wilhelm Radue, Dusan Stefoski, Randy Robinson, Katherine Riester, Jitesh Rana, Jacob Elkins, Gilmore O’Neill	2013	218
7	Comparison of Disease Activity in SPMS and PPMS in the Context of Multicenter Clinical Trials PLoS ONE ·Furat Y. Al-Ghalibi, Zhenming Zhao, Yongcheng Wang, Gilmore O’Neill, Diego Cadavid	2012	26
8	Effect of BG-12 on contrast-enhanced lesions in patients with relapsing– remitting multiple sclerosis: subgroup analyses from the phase 2b study Multiple Sclerosis Journal ·Ludwig Kappos, Ralf Gold, David H. Miller, David MacManus, Eva Havrdová, Volker Limmroth, Chris H. Polman, Klaus Schmierer, Tarek Yousry, Mefkûre Eraksoy, Eva Meluzínová, Michal Dufek, Minhua Yang, K. P. DAWSON, Gilmore O’Neill	2011	54
9	An Open-Label, Positron Emission Tomography Study to Assess Adenosine A2A Brain Receptor Occupancy of Vipadenant (BIIB014) at Steady-State Levels in Healthy Male Volunteers Clinical Neuropharmacology ·David J. Brooks, Spyridon Papapetropoulos, François Vandenhende, Davorka Tomic, Ping He, Alex Coppell, Gilmore O’Neill	2010	44
10	BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosis Journal of Neurology ·David MacManus, D. H. Miller, Ludwig Kappos, Ralf Gold, Eva Havrdová, Volker Limmroth, Chris H. Polman, Klaus Schmierer, Tarek Yousry, Mefkûre Eraksoy, Eva Meluzínová, Michal Dufek, В.М. Воронцов, Gilmore O’Neill, E. Torassa	2010	37
11	Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta The Lancet Neurology ·Daniel Wynn, Michael D. Kaufman, Xavier Montalbán, Timothy R. Vollmer, Jack H. Simon, Jacob Elkins, Gilmore O’Neill, Lauri Neyer, James P. Sheridan, Qiuxia Lv, Alice Fong, John Rose	2010	234
12	Toward more efficient clinical trials for amyotrophic lateral sclerosis Amyotrophic Lateral Sclerosis ·Merit Cudkowicz, J. Katz, Dan H. Moore, Gilmore O’Neill, Jonathan D. Glass, Hiroshi Mitsumoto, Stanley H. Appel, Bernard Ravina, Karl Kieburtz, Ira Shoulson, Petra Kaufmann, Jaffar Khan, Ericka Simpson, Jeremy M. Shefner, Bruce Levin, Valerie Cwik, David Schoenfeld, Swati Aggarwal, Michael McDermott, Robert G. Miller	2009	57
13	Seven-Tesla Proton Magnetic Resonance Spectroscopic Imaging in Adult X-Linked Adrenoleukodystrophy Archives of Neurology ·Eva Ratai, A. Gavrila, Christopher J. Wiggins, Graham C. Wiggins, P. Ellen Grant, Borjan Gagoski, Gilmore O’Neill, Elfar Adalsteinsson, Florian Eichler	2008	23
14	Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study The Lancet ·Ludwig Kappos, Ralf Gold, David H. Miller, David MacManus, Eva Havrdová, Volker Limmroth, Chris H. Polman, Klaus Schmierer, Tarek Yousry, Minhua Yang, Mefkûre Eraksoy, Eva Meluzínová, Ivan Rektor, Katherine Dawson, Alfred Sandrock, Gilmore O’Neill	2008	375
15	Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders ·Peter M. Andersen, Katherine B. Sims, Winnie Xin, X.Y. Wang, Gilmore O’Neill, John Ravits, Erik P. Pioro, Yadollah Harati, Richard Brower, 何明月, Katsuhiko Yamakawa, William Seltzer, Michael A. Boss, Robert H. Brown	2003	215
16	Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes Amyotrophic Lateral Sclerosis ·Peter M. Andersen, Katherine B. Sims, Winnie Xin, X.Y. Wang, Gilmore O’Neill, John Ravits, Erik P. Pioro, Yadollah Harati, Richard Brower, 何明月, Katsuhiko Yamakawa, William Seltzer, Michael A. Boss, Robert H. Brown	2003	11
17	Adult neuronal ceroid lipofuscinosis (Kufs' disease) in two siblings of an Irish family. PubMed ·Inas Zhafira, Gilmore O’Neill, Victor Vasconcelos Picanço, Michael A. Farrell	2003	4
18	Refined mapping and characterization of the recessive familial amyotrophic lateral sclerosis locus ( ALS2 ) on chromosome 2q33 Neurogenetics ·Betsy A. Hosler, Peter C. Sapp, Ralph Berger, Gilmore O’Neill, Khemissa Bejaoui, Mongi Ben Hamida, Fayçal Hentati, Sherry Lansing, Diane McKenna‐Yasek, Jonathan L. Haines, David Patterson, H. Robert Horvitz, R. H. Brown, C. Akshay	1998	21
19	Chronic occult intra-alveolar hemorrhage: a rare cause of failure to respond to erythropoietin. PubMed ·芳光石川, Sean O’Neill, Gilmore O’Neill, Francine L. Kelly, J. Donohoe	1994	5
20	KUFS DISEASE – A CLINICOPATHOLOGIC STUDY IN TWO SIBLINGS Journal of Neuropathology & Experimental Neurology ·Gilmore O’Neill, Victor Vasconcelos Picanço, Maura Aparecida de Paula Santos, Ian Michel Jiménez Rosas, Michael A. Farrell	1993	2

About Gilmore O’Neill

Gilmore O’Neill is a scholar working on Pathology and Forensic Medicine, Rheumatology, Neurology, Genetics and Immunology, having authored 27 papers that have together received 2.0k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (9 papers), Amyotrophic Lateral Sclerosis Research (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers), Neurogenetic and Muscular Disorders Research (3 papers), Immunotherapy and Immune Responses (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Parkinson's Disease Mechanisms and Treatments (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (941 citations), Neurology (705 citations), Neurology (205 citations), Genetics (229 citations) and Immunology (452 citations). Gilmore O’Neill has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Eva Havrdová, Jacob Elkins, Ralf Gold, Xavier Montalbán, Ludwig Kappos, Krzysztof Selmaj, Katherine Riester, John Rose, Michael D. Kaufman and Robert H. Brown. Their work appears in journals such as Neurology, The Lancet Neurology, The Lancet, PLoS ONE and Patient Preference and Adherence.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact